AVAcore placement. حسب Jacob P. Rastas (20642173)

الموضوعات:

Change in rectal temperature following pre-medication, induction and inhalant anesthesia. حسب Jacob P. Rastas (20642173)

الموضوعات:

S1 File - حسب Jacob P. Rastas (20642173)

الموضوعات:

Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. حسب Jacob P. Rastas (20642173)

الموضوعات:

Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesi... حسب Jacob P. Rastas (20642173)

الموضوعات:

Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. حسب Jacob P. Rastas (20642173)

الموضوعات:

Participant characteristics. حسب Ronald Kusolo (13200268)

الموضوعات:

Age-specific numbers and rates of DALYs (A) and deaths (B) for <i><i>Klebsiella pneumoniae</i></i> associated LRI burden by sex, 2021. DALYs disability-adjusted life years. حسب Juanjuan Li (399633)

الموضوعات:

Uganda 2023 NCD risk factor STEPS survey data. حسب Ronald Kusolo (13200268)

الموضوعات:

Uganda 2014 NCD risk factor STEPS survey data. حسب Ronald Kusolo (13200268)

الموضوعات:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. حسب Masashi Okawa (8951294)

الموضوعات:

The characteristics and clinical features of 12 patients. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. حسب Masashi Okawa (8951294)

الموضوعات:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. حسب Masashi Okawa (8951294)

الموضوعات:

The original data for the figures. حسب Masashi Okawa (8951294)

الموضوعات:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)

الموضوعات:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات: